From the scientific demo working experience with Xyrem in narcolepsy/cataplexy clients at therapeutic doses, two people reported stress and a person documented sleeplessness next abrupt discontinuation within the termination from the clinical trial; in the two individuals with panic, the frequency of cataplexy had greater markedly concurrently.Goog